All Posts: cancer
-
New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet
WASHINGTON (January 21, 2020) — Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance. The study by Georgetown Lombardi Comprehensive Cancer Center researchers appeared […]
Category: News Release
-
Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice
WASHINGTON (December 30, 2019) — Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high-fat diet fed to their mothers during pregnancy. Conversely, this treatment combination increased breast […]
Category: News Release
-
Scientific Presentations at 2019 Ruesch Symposium Inspire
(December 9, 2019) — Some of the brightest minds in gastrointestinal (GI) cancer from around the country gathered for the scientific session of the 10th-annual Ruesch Symposium at the Omnishore Hotel in Washington, DC. With a packed agenda, the daylong event on December 6 brought together clinicians, researchers, patients, caregivers, policymakers and representatives from industry for […]
Category: Lombardi Stories
-
Remission of Follicular Lymphoma for Two-Plus Years Indicates Disease-Free Status that Could Be Lifelong
Use of next-generation sequencing provides evidence of no detectable lymphoma in these patients. Media Contact Karen Teberkm463@georgetown.edu ATLANTA (December 8, 2019) — People with f
Category: News Release
-
Deeper Look at Tumor’s Genetic Mutations Challenges Current Precision Medicine Approach
WASHINGTON (December 5, 2019) — The number of genetic mutations in cancerous tumors appears to be significantly higher than previously thought, according to a new study using an advanced technology that can detect genetic mutations present only in rare cells within tumors. The finding incorporates a new mathematical approach to calculating total unique mutations in a […]
Category: News Release
-
Georgetown’s Aykut Üren Named National Academy of Inventors Fellow
Media Contact Karen Teberkm463@georgetown.edu WASHINGTON (December 3, 2019) — The National Academy of Inventors (NAI) has named Georgetown oncology researcher and educator Aykut Üren, MD, to
Category: News Release
-
Nearly One-Quarter of Completed Lung Cancer Clinical Trial Results Are Not Published
WASHINGTON (November 6, 2019) — Despite the lengthy time and money commitments that are required to conduct clinical trials, a new analysis has found that up to one-fourth of completed lung cancer clinical trial results are not published, thereby depriving patients, the research community and the public of a complete picture of the current state of […]
Category: News Release
-
DC Community Out in Strength to Support Capital Breast Care Center
(October 25, 2019) — More than 100 local community advocates and patients gathered October 25 for the 12th Annual Gift of Life Breakfast benefiting Georgetown Lombardi Comprehensive Cancer Center’s C
Category: Lombardi Stories
-
Tipo Agressivo de Câncer de Mama é Influenciado pela Ação Conjunta de Genes e RNA
Mulheres Latinas são frequentemente diagnosticadas em estágios avançados de câncer de mama do tipo triplo-negativo e podem se beneficiar de tratamentos que tem como alvo a biologia de seus tumores. WASHINGTON (22 de outubro de 2019) — Mulheres diagnosticadas com um tipo menos comum e agressivo de câncer de mama, conhecido como triplo-negativo, podem ser diferenciadas […]
Category: News Release
-
Aggressive Form of Breast Cancer Influenced by Dual Action of Genes and RNA
Latina women are typically diagnosed with aggressive triple-negative breast cancer at late stages and could benefit from treatments targeted to the biology of their disease. Media Contact: Kar
Category: News Release